HCID 57929903, compound → HCID 57929880, compound
Reaction equation
[N:1]([CH2:4][CH2:5][N:6]1[C:10]([C:11]2[CH:16]=[CH:15][C:14]([F:17])=[CH:13][C:12]=2[F:18])=[C:9]([C:19]2[CH:20]=[CH:21][C:22]3[N:23]([C:25]([CH:28]([CH3:30])[CH3:29])=[N:26][N:27]=3)[N:24]=2)[CH:8]=[N:7]1)=[N+]=[N-]>CCO.[Pt](=O)=O>[F:18][C:12]1[CH:13]=[C:14]([F:17])[CH:15]=[CH:16][C:11]=1[C:10]1[N:6]([CH2:5][CH2:4][NH2:1])[N:7]=[CH:8][C:9]=1[C:19]1[CH:20]=[CH:21][C:22]2[N:23]([C:25]([CH:28]([CH3:30])[CH3:29])=[N:26][N:27]=2)[N:24]=1Participants
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
The 6-(1-(2-azidoethyl)-5-(2,4-difluorophenyl)-1H-pyrazol-4-yl)-3-isopropyl-[1,2,4]triazolo[4,3-b]pyridazine (0.485 g, 1.19 mmol; prepared using General Procedure L.1 from 1-(2,4-difluorophenyl)-2-(3-isopropyl-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)ethanone (Preparation #K.1) with hydroxylethylhydrazine, General Procedure W with methanesulfonyl chloride, General Procedure X.1 with sodium azide) was dissolved in EtOH (20 mL) then platinum (IV) oxide (0.090 g, 0.40 mmol) was added. The mixture was hydrogenated at atmospheric pressure and ambient temperature for about 16 h then filtered through a pad of Celite®. The filtrate was concentrated under reduced pressure to give the title compound (0.447 g, 98%): LC/MS (Table 1, Method a) Rt=1.66 min; MS m/z: 384.3 (M+H)+.
Workup
- filtrationthen filtered through a pad of Celite®
- concentrationThe filtrate was concentrated under reduced pressure
Sources & evidence
- ORD record
- ord-d49c785eb2ec44c4808e3235e084eb87
- Source dataset
- uspto-grants-2012_05
- Patent number
- US08188083B2
Reaction notes
Loading…